Technicals for Suven Pharmaceuticals Limited
With the K-line above both the D-line and the 80 mark, the...
With the K-line above both the D-line and the 80 mark, the...
SUVENPHAR's forward PE is elevated, which may cap future price gains and...
The list of all important regulatory filings for Suven Pharmaceuticals Limited which...
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
An investor-focused analysis of major shifts in the financial services landscape as...
| Published | Title | Summary |
|---|---|---|
| 2025-03-27 18:06:00 | Board Meeting Intimation | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-12-28 15:34:13 | Board Meeting Intimation | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-09-27 11:38:02 | Board Meeting Intimation | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-08-02 18:56:51 | Board Meeting Intimation | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
An article analysing how new U.S. tariff policies are contributing to economic...
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...